For the Inventor, By the Inventor

Enter assignee name

San Antonio, TX, United States of America

Bionumerik Pharmaceuticals, Inc.

USPTO Granted Patents = 91

% Expired Patents = 16.5

CIPO Patents = 20

EPO Patents = 18

Trademarks = 2

Forward Citations = 604

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Frederick H Hausheer (74 out of 83 patents)

Kochat Haridas (28 out of 28 patents)

Dhanabalan Murali (18 out of 18 patents)

4. Harry Kochat (17 out of 17 patents)

5. Dasharatha Gauravaram Reddy (17 out of 17 patents)

6. Thomas J Dodd (11 out of 11 patents)

7. Qiuli Huang (10 out of 10 patents)

8. Xinghai Chen (8 out of 8 patents)

9. Seetharamulu Peddaiahgari (8 out of 11 patents)

10. Kesavaram Narkunan (5 out of 7 patents)

11. Pavankumar Nv Petluru (5 out of 5 patents)

12. Zejun Xiao (4 out of 4 patents)

13. Aulma Parker (4 out of 6 patents)

14. Peddaiahgari Seetharamulu (4 out of 4 patents)

15. Frederick Herman Hausheer (4 out of 4 patents)

Core Competencies:

Chemoprotective Methods

Camptothecin Derivatives

Cancer Treatment

Platinum Complexes

Toxicity Reduction

Dithio Compounds

Neurotoxicity Mitigation

Antineoplastic Agents

Pharmaceutical Formulations

Patient Survival

Heavy Metal Poisoning

Diabetic Neuropathy

91 patents: Sort by Forward Citations

1. 10413538 - Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer (2019-09-17),

2. 9320760 - Compositions and methods of use of compounds to increase cancer patient survival time (2016-04-26),

3. 9023805 - Increasing cancer patient survival time by administration of dithio-containing compounds (2015-05-05),

4. 8722886 - Methods for the total chemical synthesis of enantiomerically-pure 7-(2'-trimethylsilyl)ethyl camptothecin (2014-05-13),

5. 8710095 - Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity (2014-04-29),

6. 8569265 - Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3', 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof (2013-10-29),

7. 8143236 - Chemoprotective methods (2012-03-27),

8. 8026227 - Chemoprotective methods and compositions (2011-09-27),

9. 7829541 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

10. 7829540 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

11. 7829539 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

12. 7829538 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

13. 7829117 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

14. 7777060 - Platinum analogs with bis-nitrile-containing ligands (2010-08-17),

15. 7759488 - Monoazole ligand platinum analogs (2010-07-20),

BioNumerik Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing novel cancer therapies. With a strong focus on precision medicine, BioNumerik is committed to improving the lives of patients suffering from various types of cancer. The company's innovative approach combines cutting-edge research, advanced technologies, and strategic collaborations to bring groundbreaking therapies to the market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

91 Patents

#6 in San Antonio, TX

#220 in Texas

#4,101 in US

#8,426 in the World

San Antonio, TX, United States of America

Bionumerik Pharmaceuticals, Inc.

Forward Citations = 604

33 inventors:

Frederick H Hausheer (74 out of 83 patents)

Kochat Haridas (28 out of 28 patents)

Dhanabalan Murali (18 out of 18 patents)

4. Harry Kochat (17 out of 17 patents)

5. Dasharatha Gauravaram Reddy (17 out of 17 patents)

Please report any incorrect information to [email protected]

Loading…